OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
5381$1255.0059

Mipox Corp

Commodity ChemicalsVerified

Mipox Corp maintains a capital structure with a debt-to-equity ratio of 0.63, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.56, suggesting it can cover its short-term obligations with its current assets. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 10.77% and a return on assets (ROA) of 5.72%, which are key indicators of the company's efficiency in generating returns from its equity and total assets. These figures are to be compared against the industry's preferred metrics, which typically emphasize ROE and ROA as primary performance indicators. The company's gross profit margin stands at 39.1%, and its operating margin is 8.42%, both of which are in line with the industry's expectations for commodity chemical producers. The company's revenue is distributed across two segments: the Product Business and the Contract Business. The Product Business focuses on polishing films, cleaning agents, and polishing equipment, while the Contract Business provides coating, converting, and polishing services. The geographic exposure is primarily concentrated in Japan, with no significant international revenue disclosed in the latest financial report. Mipox Corp's growth trajectory is expected to remain stable, with the current fiscal year (FY) outlook indicating a modest increase in revenue. The company's capital expenditure for the latest period was -694,964,000 JPY, suggesting a reduction in investment in new facilities or equipment. This could be a strategic move to preserve cash or a reflection of the company's current operational focus. Risk factors for Mipox Corp include the potential for liquidity constraints due to its negative net cash position and the reliance on debt financing. The company's dilution potential is currently assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the risk assessment highlights the need for continued monitoring of the company's liquidity position. Recent events include the publication of the 2023 annual report, which provides detailed financial and operational data. The report also includes insights into the company's strategic direction and market positioning. Analyst estimates for the upcoming fiscal year suggest a mean EPS estimate of 39.70 JPY, which is lower than the last actual EPS of 64.04 JPY, indicating potential downward pressure on earnings.

30-day price · 5381+110.00 (+12.3%)
Low$853.00High$1377.00Close$1002.00As of18 May, 00:00 UTC
Profile
CompanyMipox Corp
Ticker5381.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Mipox Corp is a Japan-based company engaged in the manufacture and sale of polishing-related products and contract processing services, primarily serving the semiconductor and precision manufacturing industries.

Classification. Mipox Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Mipox Corp maintains a capital structure with a debt-to-equity ratio of 0.63, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.56, suggesting it can cover its short-term obligations with its current assets. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 10.77% and a return on assets (ROA) of 5.72%, which are key indicators of the company's efficiency in generating returns from its equity and total assets. These figures are to be compared against the industry's preferred metrics, which typically emphasize ROE and ROA as primary performance indicators. The company's gross profit margin stands at 39.1%, and its operating margin is 8.42%, both of which are in line with the industry's expectations for commodity chemical producers. The company's revenue is distributed across two segments: the Product Business and the Contract Business. The Product Business focuses on polishing films, cleaning agents, and polishing equipment, while the Contract Business provides coating, converting, and polishing services. The geographic exposure is primarily concentrated in Japan, with no significant international revenue disclosed in the latest financial report. Mipox Corp's growth trajectory is expected to remain stable, with the current fiscal year (FY) outlook indicating a modest increase in revenue. The company's capital expenditure for the latest period was -694,964,000 JPY, suggesting a reduction in investment in new facilities or equipment. This could be a strategic move to preserve cash or a reflection of the company's current operational focus. Risk factors for Mipox Corp include the potential for liquidity constraints due to its negative net cash position and the reliance on debt financing. The company's dilution potential is currently assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the risk assessment highlights the need for continued monitoring of the company's liquidity position. Recent events include the publication of the 2023 annual report, which provides detailed financial and operational data. The report also includes insights into the company's strategic direction and market positioning. Analyst estimates for the upcoming fiscal year suggest a mean EPS estimate of 39.70 JPY, which is lower than the last actual EPS of 64.04 JPY, indicating potential downward pressure on earnings.
Key takeaways
  • Mipox Corp operates in the Commodity Chemicals industry with a focus on polishing-related products and contract processing.
  • The company's ROE of 10.77% and ROA of 5.72% indicate strong profitability relative to its equity and asset base.
  • The company's liquidity position is moderate, with a current ratio of 1.56 and a negative net cash position after debt.
  • Revenue is primarily concentrated in Japan, with no significant international exposure disclosed.
  • The company's capital expenditure for the latest period was negative, suggesting a strategic focus on cost control.
  • Analyst estimates for the upcoming fiscal year suggest potential downward pressure on earnings.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$11.17B
Gross profit$4.37B
Operating income$941.6M
Net income$911.9M
R&D
SG&A
D&A
SBC
Operating cash flow$1.60B
CapEx-$695.0M
Free cash flow$863.0M
Total assets$15.93B
Total liabilities$7.47B
Total equity$8.46B
Cash & equivalents$2.41B
Long-term debt$5.34B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1255.00
Market cap$17.37B
Enterprise value$20.31B
P/E19.1
Reported non-GAAP P/E
EV/Revenue1.8
EV/Op income21.6
EV/OCF12.7
P/B2.0
P/Tangible book2.0
Tangible book$8.46B
Net cash-$2.93B
Current ratio1.6
Debt/Equity0.6
ROA5.7%
ROE10.8%
Cash conversion1.8%
CapEx/Revenue-6.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric5381Activity
Op margin8.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin8.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin39.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-6.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity63.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean EPS estimate39.70 JPY
Last actual EPS64.04 JPY
Mean revenue estimate12,000,000,000 JPY
Last actual revenue11,172,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:52 UTC#a246abb9
Market quoteclose JPY 1255.00 · shares 0.01B diluted
no public URL
2026-05-10 10:52 UTC#bb6db637
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 10:55 UTCJob: be17c4ed